IOVA — Iovance Biotherapeutics Inc · rev $263.5M

Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.

Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. IOVA currently screens at market cap $1.89B.

Use this IOVA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IOVA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IOVA SEC filings page. Lician reads the product cache first so this HTML stays unique to Iovance Biotherapeutics Inc even when a live quote feed is slow.

Iovance Biotherapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full IOVA income, balance, and cash tables.

  • Revenue$263.5M
  • Net Income-$391.0M
  • Total Assets$913.2M
  • Total Debt$0
  • Free Cash Flow-$336.2M

IOVA recent filings